NCT05113576View on ClinicalTrials.gov

Combining Intratumoral Metabolic Heterogeneity and Dissemination Feature (Dmax) on 18F-FDG PET/CT Improves Prognosis Prediction in DLBCL

CompletedOBSERVATIONAL
Enrollment

132

Participants

Timeline

Start Date

October 10, 2013

Primary Completion Date

May 30, 2020

Study Completion Date

June 30, 2021

Conditions
Diffuse Large B-cell Lymphoma
Trial Locations (1)

310009

Department of Nuclear Medicine and PET/CT Center, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou

All Listed Sponsors
lead

Second Affiliated Hospital, School of Medicine, Zhejiang University

OTHER

NCT05113576 - Combining Intratumoral Metabolic Heterogeneity and Dissemination Feature (Dmax) on 18F-FDG PET/CT Improves Prognosis Prediction in DLBCL | Biotech Hunter | Biotech Hunter